Insider Option Purchases Signal Potential Upside for Nuwellis Amid New Catheter Patent
Insider option buying at Nuwellis hints at a potential upside from its new dual‑lumen catheter patent – but investors should watch regulatory milestones and market uptake for real value.
3 minutes to read